Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Osteosarcoma
>>
Novartis
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
figitumumab
(CP-751,871) / Novartis
patupilone
(EPO 906) / Novartis
Promacta
(eltrombopag) / Novartis
Votrient
(pazopanib) / Novartis, BeiGene